Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy
- 13 February 2013
- journal article
- research article
- Published by Elsevier BV in Neuromuscular Disorders
- Vol. 23 (4), 306-312
- https://doi.org/10.1016/j.nmd.2013.01.008
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Validity of a Smartphone-based instrumented Timed Up and GoGait & Posture, 2012
- Strength training and albuterol in facioscapulohumeral muscular dystrophyNeurology, 2004
- A comparison of muscle strength testing techniques in amyotrophic lateral sclerosisNeurology, 2003
- Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophyNeuromuscular Disorders, 2001
- A Prospective, Quantitative Study of the Natural History of Facioscapulohumeral Muscular Dystrophy (FSHD)Neurology, 1997
- Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1Human Molecular Genetics, 1996
- The FSHD-Associated Repeat, D4Z4, Is a Member of a Dispersed Family of Homeobox-Containing Repeats, Subsets of Which Are Clustered on the Short Arms of the Acrocentric ChromosomesGenomics, 1995
- Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.1994
- Facioscapulohumeral muscular dystrophy (FSHD)Neurology, 1994
- Clinical trial in duchenne dystrophy. I. The design of the protocolMuscle & Nerve, 1981